Navigating The Genomic Regulatory Landscape

Join us for this in-depth, two-day workshop and explore current regulatory issues and challenges related to genomics.  Lecturers from academia, industry, and the legal profession will discuss the impact of regulations on genomics in the context of medicine, ethics and patient privacy, legal strategies, the use of big data, and the commercial landscape.  The workshop will consist of a combination of lectures, regulatory case studies, an onsite tour at the biotechnology company Illumina and opportunities for networking.

Objectives:

• Gain an in-depth understanding of the current challenges and opportunities faced by the genomics regulatory environment
• Apply critical skills in regulatory science and how it applies to an examination of translational, clinical, ethical, legal and data challenges for genomic topics
• Evaluate the impact of laws, policies and regulations on the genomic industry

Benefits:

• World-class speakers from academia, industry and the legal profession
• Tour and lecture at Illumina, Inc.
• Breakfast and lunch included (lunch only provided on first day)
• Reception at Rock Bottom Restaurant and Brewery in La Jolla, CA
• Earn 1.5 units of continuing education credit

Confirmed Speakers:

• Paul Rejto, Head of Oncology Translational Research, Pfizer, Inc.
• Iván Godinez, Ph.D. Project Manager, Scientific Research, Illumina
• Ruth Waterman, Associate Professor, Anesthesiology, UC San Diego
• Dale Hunt, Partner, Hahn Loeser & Parks
• Ashley Van Zeeland, Chief Technology Officer, Human Longevity, Inc.
• Sally Howard, J.D., Head of Regulatory Affairs and Policy, Human Longevity, Inc.
• Camille Nebeker, Director, Research Ethics, Scripps Translational Science Institute
• Michael Kalichman, Director, Research Ethics Program, UC San Diego
• Hannah Carter, Assistant Professor, School of Medicine, UC San Diego
• Tim Mackey, Ph.D., Director, Global Health Policy Institute